Autonomix Medical (AMIX) Stock Price, News & Analysis

Company Overview

Autonomix Medical, Inc. is a medical device company developing catheter-based technologies for the detection and treatment of conditions involving the peripheral nervous system. The company’s platform is designed to identify neural signals in real time, with the goal of helping physicians locate and selectively treat targeted nerves during minimally invasive procedures.

Autonomix’s lead development program is focused on pain associated with pancreatic cancer. Its technology is intended to support targeted nerve ablation, potentially offering an alternative approach for managing pain while reducing the need for more extensive procedures. The platform may also have applications in other conditions involving abnormal nerve activity, including certain cardiovascular and neurological disorders.

The company is headquartered in The Woodlands, Texas, and its technology remains in the development and clinical evaluation stage. Autonomix Medical’s common stock trades on the Nasdaq Capital Market under the symbol AMIX.

Key Stats

• Today's Range: $1.46 to $1.68
• 50-Day Range: $1.52 to $5.32
• 52-Week Range: $1.46 to $32.55
• Volume: 85,937 shs
• Average Volume: 55,330 shs
• Market Capitalization: $1.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $42.00
• Consensus Rating: Hold

Autonomix Medical Stock Analysis - MarketRank™

Autonomix Medical scored higher than 35% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Autonomix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

Upside Potential

Autonomix Medical has a consensus price target of $42.00, representing about 2,663.2% upside from its current price of $1.52.

Amount of Analyst Coverage

Autonomix Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Autonomix Medical are expected to grow in the coming year, from ($20.17) to ($17.44) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Autonomix Medical is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Autonomix Medical is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Autonomix Medical has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.43% of the float of Autonomix Medical has been sold short.

Short Interest Ratio / Days to Cover

Autonomix Medical has a short interest ratio ("days to cover") of 0.21, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Autonomix Medical has recently increased by 119.85%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Autonomix Medical does not currently pay a dividend.

Dividend Growth

Autonomix Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 3 people have searched for AMIX on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.

MarketBeat Follows

2 people have added Autonomix Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Autonomix Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

5.50% of the stock of Autonomix Medical is held by insiders.

Percentage Held by Institutions

10.78% of the stock of Autonomix Medical is held by institutions.

Company Calendar

• Last Earnings: 8/12/2026
• Today: 11/08/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:AMIX
• Previous Symbol: NASDAQ:AMIX
• CIK: 1617867
• Web: autonomix.com
• Phone: 713-588-6150
• Fax: N/A
• Employees: 11
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Autonomix Medical: $42.00
• High Price Target: $42.00
• Low Price Target: $42.00
• Potential Upside/Downside: +2,663.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($41.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.72 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -267.73%
• Return on Assets: -216.75%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.85
• Quick Ratio: 4.85

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $10.85 per share
• Price / Book: 0.14

Miscellaneous

• Outstanding Shares: 971,000
• Free Float: 918,000
• Market Cap: $1.48 million
• Optionable: N/A
• Beta: -0.70